Entecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleosidenaive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B | AVESİS

Bezmialem Vakıf University Research Information System

Entecavir (ETV) demonstrates consistent responses throughout baseline demographic subgroups for the treatment of nucleosidenaive, HBeAg(+) and HBeAg(-) patients with chronic hepatitis B

Copy For Citation

Shouval D., Senturk H., Gish R., Chang T., Yurdaydin C., Lai C., ...More

40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Paris, France, 13 - 17 April 2005, vol.42, pp.192

Publication Type: Conference Paper / Summary Text
Volume: 42
City: Paris
Country: France
Page Numbers: pp.192
Bezmialem Vakıf University Affiliated: Yes